ISIN:DE000BGAG981

EQS-News: Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants

Retrieved on: 
Montag, Juli 31, 2023
Infection, Veterinary medicine, Silver, Medicine, Noetics, Hygiene, LOI, ISIN, Growth, Health, FDA, Trauma, Medical device

Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the trauma sector.

Key Points: 
  • Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the trauma sector.
  • The medical device manufacturer intends to use Bio-Gate's "HyProtectTM" coating process for its own implants in human medicine following the FDA approval process.
  • With the North American medical device manufacturer, Bio-Gate has gained another important company as a partner for its "HyProtect" coating technology and can develop significant growth potential in applications for human medicine in the future.
  • Bio-Gate uses the "HyProtect" technology to coat medical devices with an ultra-thin layer containing polysiloxane and silver.